Hippocampus in Schizophrenia and Bipolar Disorder
精神分裂症和双相情感障碍中的海马体
基本信息
- 批准号:6840843
- 负责人:
- 金额:$ 28.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-01-01 至 2008-12-31
- 项目状态:已结题
- 来源:
- 关键词:NMDA receptorsbipolar depressionbrain mappingbrain morphologycell population studygene expressiongene expression profilingglutamate decarboxylasehippocampushistologyhuman tissueimmunocytochemistryin situ hybridizationinterneuronspostmortemprotein localizationproteomicsschizophreniasomatostatinstereotaxic techniques
项目摘要
This is a New Investigator proposal to study the cellular and molecular profile of the hippocampus in schizophrenia (SZ) and bipolar disorder (BD). Decreased volume of the hippocampus is one of the most consistent findings of postmortem and structural neuroimaging studies of SZ. There is emerging evidence from neuroimaging studies that the hippocampus is also smaller in BD patients, but this has not been studied yet in postmortem specimens. The
cellular basis of hippocampal volume change in psychosis remains poorly understood, but it appears likely that cellular changes affect distinctsubpopulations of interneurons and that molecular changes involve genes related to GABAergic and glutamatergic neurotransmission.
The applicant is proposing to study, in the same specimens, three aspects of hippocampal pathology in SZ and BD: cell number, protein expression, and gene expression. Using this integrated approach the applicant will test the hypothesis that decreased hippocampal volume in SZ and BD is regionally selective and that cellular changes are affecting subpopulations of intemeurons differentially. First, whole hippocampus preparations and stereological methods will be used to determine hippocampal volume and the total number of hippocampal neurons. We
hypothesize that hippocampal changes in SZ and BD are not widespread and diffuse but selective for interneurons in the anterior region and in sectors CA2-4. Furthermore, we hypothesize that SZ is characterized by selective changes
in the cell-poor layers of the hippocampus, i.e. stratum oriens and stratum radiatum/lacunosum/moleculare. Second, stereological methods and immunocytochemical markers will be employed to determine the total number of subsets of hippocampal interneurons. We hypothesize that the total number of parvalbumin-positive hippocampal interneurons
will be decreased in SZ, whereas the total number of somatostatin-positive interneurons will be changed in BD. Third, in-situ hybridization experiments will test the hypothesis of a selective decrease of genes expressed in hippocampal interneurons. We hypothesize that the expression of glutamic acid decarboxylase (GAD) mRNA will be decreased in BD and that the expression of the mRNA coding for the NMDA receptor subunit 2C, localized preferentially in interneurons of the human hippocampus, is decreased in SZ.
The proposed studies are designed to better understand hippocampal pathology in SZ and BD. A regionally specific volume change together with a selective dysfunction of interneurons could provide the structural basis for a role of the ..hippoc.ampus inthe cognitive deficits and clinical symptoms seen in patients with SZ and BD.
这是一个新的研究者的建议,研究海马在精神分裂症(SZ)和双相情感障碍(BD)的细胞和分子概况。海马体积减少是SZ死后和结构神经影像学研究最一致的结果之一。神经影像学研究中有新的证据表明BD患者的海马也较小,但这尚未在死后标本中进行研究。的
精神病中海马体积变化的细胞基础仍然知之甚少,但似乎细胞变化影响不同的中间神经元亚群,分子变化涉及GABA能和多巴胺能神经传递相关基因。
申请方建议在相同的标本中研究SZ和BD海马病理学的三个方面:细胞数量、蛋白表达和基因表达。使用这种综合方法,申请人将检验以下假设:SZ和BD中海马体积的减少具有区域选择性,并且细胞变化差异性地影响中间神经元的亚群。首先,将使用整个海马制备物和体视学方法来确定海马体积和海马神经元的总数。我们
假设SZ和BD的海马变化不是广泛和弥漫的,而是对前部区域和CA 2 -4区的中间神经元具有选择性。此外,我们假设,SZ的特点是选择性变化
在海马的细胞贫乏层,即定向层和放射层/腔隙层/分子层中。其次,采用体视学方法和免疫细胞化学标记物确定海马中间神经元亚群的总数。我们假设小白蛋白阳性海马中间神经元的总数
SZ中生长抑素阳性中间神经元的数量将减少,而BD中生长抑素阳性中间神经元的总数将改变。第三,原位杂交实验将测试海马中间神经元中表达的基因的选择性减少的假设。我们假设,谷氨酸脱羧酶(GAD)mRNA的表达将在BD和表达的NMDA受体亚基2C,本地化优先在人海马的中间神经元的mRNA编码减少,在SZ。
拟定的研究旨在更好地了解SZ和BD的海马病理学。区域特定体积变化以及中间神经元的选择性功能障碍可以为神经元的作用提供结构基础。在SZ和BD患者中观察到的认知缺陷和临床症状中,
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHAN HECKERS其他文献
STEPHAN HECKERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHAN HECKERS', 18)}}的其他基金
The General Factor of Psychopathology in Psychosis and Severe Mental Illness
精神病和严重精神疾病的精神病理学一般因素
- 批准号:
10166015 - 财政年份:2019
- 资助金额:
$ 28.98万 - 项目类别:
The General Factor of Psychopathology in Psychosis and Severe Mental Illness
精神病和严重精神疾病的精神病理学一般因素
- 批准号:
10413229 - 财政年份:2019
- 资助金额:
$ 28.98万 - 项目类别:
The General Factor of Psychopathology in Psychosis and Severe Mental Illness
精神病和严重精神疾病的精神病理学一般因素
- 批准号:
10640893 - 财政年份:2019
- 资助金额:
$ 28.98万 - 项目类别:
The General Factor of Psychopathology in Psychosis and Severe Mental Illness
精神病和严重精神疾病的精神病理学一般因素
- 批准号:
10260599 - 财政年份:2019
- 资助金额:
$ 28.98万 - 项目类别:
相似海外基金
Psilocybin Assisted Psychotherapy for Bipolar Depression: An fMRI Emotional-Processing Pilot Study
裸盖菇素辅助双相抑郁心理治疗:功能磁共振成像情绪处理试点研究
- 批准号:
486939 - 财政年份:2023
- 资助金额:
$ 28.98万 - 项目类别:
Miscellaneous Programs
Repeated Ketamine Infusions for Cognitive Impairment in Treatment-Resistant Bipolar Depression
反复输注氯胺酮治疗难治性双相抑郁症的认知障碍
- 批准号:
486443 - 财政年份:2022
- 资助金额:
$ 28.98万 - 项目类别:
Studentship Programs
Reward and stress: Developing neuroimaging biomarkers for bipolar depression
奖励和压力:开发双相抑郁症的神经影像生物标志物
- 批准号:
2748645 - 财政年份:2022
- 资助金额:
$ 28.98万 - 项目类别:
Studentship
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study
裸盖菇素对治疗难治性双相抑郁症的神经生物学作用:情绪处理功能磁共振成像初步研究
- 批准号:
486577 - 财政年份:2022
- 资助金额:
$ 28.98万 - 项目类别:
Studentship Programs
Theta-burst stimulation for bipolar depression: A randomized controlled trial
θ 爆发刺激治疗双相抑郁症:一项随机对照试验
- 批准号:
469571 - 财政年份:2022
- 资助金额:
$ 28.98万 - 项目类别:
Operating Grants
Cannabidiol Adjunctive Therapy for Acute Bipolar Depression: A Randomized Double-Blind Placebo Controlled Trial
大麻二酚辅助治疗急性双相抑郁症:随机双盲安慰剂对照试验
- 批准号:
444068 - 财政年份:2021
- 资助金额:
$ 28.98万 - 项目类别:
Operating Grants
Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized, Midazolam-Controlled Phase II Clinical Trial
重复氯胺酮输注治疗难治性双相抑郁症:一项随机、咪达唑仑对照的 II 期临床试验
- 批准号:
434675 - 财政年份:2020
- 资助金额:
$ 28.98万 - 项目类别:
Operating Grants
Next Generation Drugs for Bipolar Depression and Maintenance
治疗双相抑郁症和维持治疗的下一代药物
- 批准号:
9555300 - 财政年份:2018
- 资助金额:
$ 28.98万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10080262 - 财政年份:2018
- 资助金额:
$ 28.98万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10588254 - 财政年份:2018
- 资助金额:
$ 28.98万 - 项目类别:














{{item.name}}会员




